Cargando…

The age factor in survival of a population cohort of well-differentiated thyroid cancer

Well-differentiated thyroid carcinoma (WDTC) represents a group of thyroid cancers with excellent prognosis. Age, a well-recognized risk factor for WDTC, has been consistently included in various prognostic scoring systems. An age threshold of 45 years is currently used by the American Joint Cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mazurat, Andrea, Torroni, Andrea, Hendrickson-Rebizant, Jane, Benning, Harbinder, Nason, Richard W, Pathak, K Alok
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioScientifica 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3845683/ https://www.ncbi.nlm.nih.gov/pubmed/24008393 http://dx.doi.org/10.1530/EC-13-0056

Ejemplares similares

The changing face of thyroid cancer in a population-based cohort
por: Alok Pathak, K, et al.
Publicado: (2013)

A prospective cohort study to assess the role of FDG-PET in differentiating benign and malignant follicular neoplasms
por: Pathak, K. Alok, et al.
Publicado: (2016)

Clinical presentation and survival outcomes of well‐differentiated thyroid cancer in Filipinos
por: Megwalu, Uchechukwu C., et al.
Publicado: (2021)

Comparison of Survival and Risk Factors of Differentiated Thyroid Cancer in the Geriatric Population
por: Yu, Lujiao, et al.
Publicado: (2020)

Mutation Profile of Well-Differentiated Thyroid Cancer in Asians
por: Song, Young Shin, et al.
Publicado: (2015)

Rapid thyroid nodule growth is not a marker for well-differentiated thyroid cancer
por: Falch, Claudius, et al.
Publicado: (2015)

Clinicopathological and Survival Outcomes of Well-Differentiated Thyroid Carcinoma Undergoing Dedifferentiation: A Retrospective Study from FUSCC
por: Ma, Ben, et al.
Publicado: (2018)

Regional Variation across Canadian Centers in Radioiodine Administration for Thyroid Remnant Ablation in Well-Differentiated Thyroid Cancer Diagnosed in 2000–2010
por: Rachinsky, I., et al.
Publicado: (2016)

Molecular Pathogenesis and Targeted Therapies in Well-Differentiated Thyroid Carcinoma
por: Kim, Jung Guk
Publicado: (2014)

Risk Factors for Recurrence in Filipinos with Well-Differentiated Thyroid Cancer
por: Lo, Tom Edward Ngo, et al.
Publicado: (2015)

Well-Differentiated Thyroid Cancer: The Philippine General Hospital Experience
por: Lo, Tom Edward N., et al.
Publicado: (2016)

Molecular Profile of Locally Aggressive Well Differentiated Thyroid Cancers
por: Mady, Leila J., et al.
Publicado: (2020)

Surgical Management of Tracheal Invasion by Well-Differentiated Thyroid Cancer
por: Matsumoto, Fumihiko, et al.
Publicado: (2021)

Prophylactic Central Neck Dissection in Well-differentiated Thyroid Cancer
por: Gršić, Krešimir, et al.
Publicado: (2020)

Patient and tumor factors contributing to distant metastasis in well-differentiated thyroid cancer: a retrospective cohort study
por: Khan, Usman, et al.
Publicado: (2020)

Anaplastic carcinoma following well-differentiated thyroid cancer: etiological considerations.
por: Kapp, D. S., et al.
Publicado: (1982)

Prognostic Factors in Patients with Multiple Recurrences of Well-Differentiated Thyroid Carcinoma
por: Holler, Theresa, et al.
Publicado: (2009)

Well-differentiated (Marschalko-type) plasmacytoma resembling thyroid follicular structures
por: Lara-Torres, César O., et al.
Publicado: (2008)

Sorafenib in radioactive iodine-refractory well-differentiated metastatic thyroid cancer
por: McFarland, Daniel C, et al.
Publicado: (2014)

Well-Differentiated Thyroid Cancer Invading the Trachea in a Pediatric Patient
por: Mott, Nicole, et al.
Publicado: (2021)

Protocol for an economic analysis of the randomised controlled trial of Improving the Well-being of people with Opioid Treated CHronic pain: I-WOTCH Study
por: Manchira Krishnan, Sheeja, et al.
Publicado: (2020)

THU224 Is Chronic Lymphocytic Thyroiditis Associated With Aggressive Differentiated Thyroid Cancer In A Predominantly Hispanic Pediatric Population?
por: Solano, Natalia, et al.
Publicado: (2023)

Role of adjuvant postoperative external beam radiotherapy for well differentiated thyroid cancer
por: Kwon, Jeanny, et al.
Publicado: (2013)

Aberrant Expression of Posterior HOX Genes in Well Differentiated Histotypes of Thyroid Cancers
por: Cantile, Monica, et al.
Publicado: (2013)

Cyclin D1 in well differentiated thyroid tumour of uncertain malignant potential
por: Lamba Saini, Monika, et al.
Publicado: (2015)

Radiofrequency Ablation to Treat Loco-Regional Recurrence of Well-Differentiated Thyroid Carcinoma
por: Lee, Sun Jin, et al.
Publicado: (2014)

Method of Detection of Well-Differentiated Thyroid Cancers in Obese and Non-Obese Patients
por: Zagzag, Jonathan, et al.
Publicado: (2016)

Therapeutic Outcome of Second Primary Malignancies in Patients with Well-Differentiated Thyroid Cancer
por: Liou, Miaw-Jene, et al.
Publicado: (2016)

Methylation status of TSHr in well-differentiated thyroid cancer by using cytologic material
por: Kartal, Kinyas, et al.
Publicado: (2015)

Immunocytochemistry Test of Protein BRAF Expression for Diagnosis of Well Differentiated Thyroid Carcinoma
por: Sudarsa, I. Wayan, et al.
Publicado: (2018)

Creating Prognostic Systems for Well-Differentiated Thyroid Cancer Using Machine Learning
por: Yang, Charles Q., et al.
Publicado: (2019)

The efficacy of radioactive iodine for the treatment of well-differentiated thyroid cancer with distant metastasis
por: Lin, Jen-Der, et al.
Publicado: (2018)

Clinical Course from Diagnosis to Death in Patients with Well-Differentiated Thyroid Cancer
por: Park, Hyunju, et al.
Publicado: (2020)

Management of Recurrent Well-Differentiated Thyroid Carcinoma in the Neck: A Comprehensive Review †
por: Cavalheiro, Beatriz G., et al.
Publicado: (2023)

Role of computed tomography in the evaluation of regional metastasis in well-differentiated thyroid cancer
por: Vaish, Richa, et al.
Publicado: (2023)

Thyroid hormone replacement one day before (131)I therapy in patients with well-differentiated thyroid cancer
por: Kayano, Daiki, et al.
Publicado: (2013)

Postoperative radioiodine therapy impact on survival in poorly differentiated thyroid carcinoma: a population-based study
por: Xu, Lei, et al.
Publicado: (2021)

Protein arginine N-methyltransferase 2 plays a noncatalytic role in the histone methylation activity of PRMT1
por: Rowley, Michael J., et al.
Publicado: (2023)

PRIMA 2015: 18th international conference, Bertinoro, Italy, October 26-30, 2015, proceedings
por: Chen, Qingliang, et al.
Publicado: (2015)

A novel protein expression signature differentiates benign lipomas from well-differentiated liposarcomas
por: Mather, Quang, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_51bh5vd8i1p05g6sv4pp58lqg5